Skip to main content

Neutra Corp

corporate_fare Company Profile

Neutra Corp

NTRR·OTC·Life Sciences·CIK 0001512886

Neutra Corp markets and participates in the nutraceutical space, focusing on products derived from natural and organic origins. The company was incorporated in Nevada on January 11, 2011, and reincorporated in Wyoming on August 16, 2019. Neutra Corp plans to research and introduce new technology to the nutraceutical space, which encompasses natural medicine focused on natural remedies and the body's self-healing ability. A key sub-market the company intends to participate in is the medical cannabis market. Neutra Corp intends to use a nutraceutical contractor to private label all its products, selling them under its own brand. The company's fiscal year ends on January 31. Neutra Corp actively seeks out new technologies and products for the global cannabis market, including advancements in lighting, dosage devices, pesticide replacements, and plant enhancers. On January 23, 2018, Neutra Corp entered into an agreement with Artillery Labs to sell and market natural nutraceuticals online, specifically its own line of all-natural and legal CBD products, utilizing Artillery Labs' online sales infrastructure. Artillery Labs is to be paid $25,000 upon the successful marketing launch of a product. On August 30, 2019, Neutra Corp acquired all outstanding stock of Vivis Corporation, a Wyoming corporation, from Sydney Jim, the CEO. The purchase price for Vivis was $35,000 cash, plus a royalty of 40 percent of gross revenue until $100,000 is paid, declining to 25 percent until an additional $100,000 has been paid, followed by a 10 percent royalty in perpetuity.

Neutra Corp (OTC:NTRR) is a publicly traded company in the Life Sciences sector. Wiseek monitors NTRR SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Neutra Life Sciences Forms Women's Health JV, Secures New Clinical Trials
Browse all tickers starting with N →
$0.0001
52-week range · as of 2026-06-29 $0.000001 – $0.0003
Market cap
$583.58K
Volume
135K (0.1× avg)
3-mo avg 2.4M
Live data · 2026-06-29 21:56 UTC · After hours

show_chartPrice Chart

Loading chart...

feed NTRR - Latest Insights

NTRR
Jun 29, 2026, 3:29 PM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.0001
Real-time Price: $0.0001 info
Change: $0 (0%) info
Market Cap: $583.58K info